US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
US4844893A
(en)
|
1986-10-07 |
1989-07-04 |
Scripps Clinic And Research Foundation |
EX vivo effector cell activation for target cell killing
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク,インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
EP0474727B1
(en)
|
1989-05-19 |
1997-07-23 |
Genentech, Inc. |
Her2 extracellular domain
|
US5541104A
(en)
|
1991-05-23 |
1996-07-30 |
Ludwig Institute For Cancer Research |
Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1
|
US5342774A
(en)
|
1991-05-23 |
1994-08-30 |
Ludwig Institute For Cancer Research |
Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
|
US5925729A
(en)
|
1991-05-23 |
1999-07-20 |
Ludwig Institute For Cancer Research |
Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
|
US6037135A
(en)
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
EP0633929B1
(en)
|
1992-04-01 |
2004-03-03 |
The Rockefeller University |
METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS
|
US6077519A
(en)
|
1993-01-29 |
2000-06-20 |
University Of Pittsburgh |
Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US5419900A
(en)
|
1993-05-19 |
1995-05-30 |
The United States Of America As Represented By The Department Of Of Health And Human Services |
Immunologic enhancement with intermittent interleukin-2 therapy
|
US5550214A
(en)
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
US5874560A
(en)
|
1994-04-22 |
1999-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Melanoma antigens and their use in diagnostic and therapeutic methods
|
WO1995029193A2
(en)
|
1994-04-22 |
1995-11-02 |
The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services |
Melanoma antigens
|
US6300090B1
(en)
|
1994-07-29 |
2001-10-09 |
The Rockefeller University |
Methods of use of viral vectors to deliver antigen to dendritic cells
|
WO1996018409A1
(en)
|
1994-12-14 |
1996-06-20 |
The Scripps Research Institute |
In vivo activation of tumor-specific cytotoxic t cells
|
US6010905A
(en)
|
1995-01-27 |
2000-01-04 |
The United States Of America As Represented By The Department Of Health & Human Services |
Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells
|
US5643786A
(en)
|
1995-01-27 |
1997-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for isolating dendritic cells
|
US5635363A
(en)
|
1995-02-28 |
1997-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
|
US6514942B1
(en)
|
1995-03-14 |
2003-02-04 |
The Board Of Regents, The University Of Texas System |
Methods and compositions for stimulating T-lymphocytes
|
US5788963A
(en)
|
1995-07-31 |
1998-08-04 |
Pacific Northwest Cancer Foundation |
Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
US6455678B1
(en)
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
US5843633A
(en)
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
US6458585B1
(en)
|
1996-08-14 |
2002-10-01 |
Nexell Therapeutics Inc. |
Cytokine-free culture of dendritic cells
|
US7368531B2
(en)
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
AU7499498A
(en)
|
1997-05-21 |
1998-12-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods and compositions for making dendritic cells from expanded populations ofmonocytes and for activating t cells
|
JP2002508167A
(ja)
|
1997-12-18 |
2002-03-19 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
110個のヒト分泌タンパク質
|
US20020034819A1
(en)
|
1998-02-23 |
2002-03-21 |
Alan K. Smith |
Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
|
US20020192211A1
(en)
|
1998-03-17 |
2002-12-19 |
Hudziak Robert M. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
US6248329B1
(en)
*
|
1998-06-01 |
2001-06-19 |
Ramaswamy Chandrashekar |
Parasitic helminth cuticlin nucleic acid molecules and uses thereof
|
US20020115213A1
(en)
|
1998-08-14 |
2002-08-22 |
Northeastern Ohio Universities Of Medicine |
Engraftable neural progenitor & stem cells for brain tumor therapy
|
US7186409B2
(en)
|
1998-08-14 |
2007-03-06 |
The Children's Medical Center Corporation |
Neural stem cells and use thereof for brain tumor therapy
|
CN1330557A
(zh)
|
1998-09-15 |
2002-01-09 |
匹兹堡大学联邦***高等教育 |
原位注射具有基因上增进细胞因子表达的抗原呈递细胞
|
US7504490B1
(en)
|
1998-10-16 |
2009-03-17 |
Oscient Pharmaceuticals Corporation |
Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
|
AU1598500A
(en)
|
1998-10-26 |
2000-05-15 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Hla-a2 and hla-dr specific peptide epitopes from the melanoma antigen trp2
|
GB9824306D0
(en)
|
1998-11-05 |
1998-12-30 |
Isis Innovation |
Method for producing dendritic dells
|
JP2002533416A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー.ディー.サール & カンパニー |
新形成の治療における組み合わせ治療としてのシクロオキシゲナーゼ−2インヒビターおよび一つまたはそれ以上の抗腫瘍薬の使用方法
|
AU2604200A
(en)
|
1999-01-08 |
2000-07-24 |
Panacos Pharmaceuticals, Inc. |
Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41
|
ES2290032T3
(es)
|
1999-05-03 |
2008-02-16 |
Neuro Therapeutics Ab |
Procedimiento para la produccion de neuronas dopaminergicas.
|
US20040031072A1
(en)
*
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
US6566395B1
(en)
|
1999-05-25 |
2003-05-20 |
Biomedicines, Inc. |
Methods of treating proliferative disorders
|
AU6620300A
(en)
|
1999-08-03 |
2001-02-19 |
Ohio State University, The |
Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
|
EP1242049A4
(en)
|
1999-12-13 |
2005-01-05 |
Epimmune Inc |
HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINES
|
US20070098776A1
(en)
|
1999-12-13 |
2007-05-03 |
Fikes John D |
HLA class I A2 tumor associated antigen peptides and vaccine compositions
|
CA2398136A1
(en)
|
2000-02-08 |
2001-08-16 |
The Penn State Research Foundation |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
US20060003323A1
(en)
|
2000-03-01 |
2006-01-05 |
John Alsobrook |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
AU4744201A
(en)
|
2000-03-15 |
2001-09-24 |
Childrens Medical Center |
Systemic gene delivery vehicles for the treatment of tumors
|
US20020076707A1
(en)
|
2000-06-30 |
2002-06-20 |
David Mack |
Novel methods of diagnosing cancer, compositions, and methods of screening for cancer modulators
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
AU2001288863A1
(en)
|
2000-09-15 |
2002-03-26 |
Ortho-Mcneil Pharmaceutical, Inc. |
Compositions and methods for inducing specific cytolytic t cell responses
|
EP1356043A2
(en)
|
2000-10-04 |
2003-10-29 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
|
US20030202963A1
(en)
|
2000-10-12 |
2003-10-30 |
Cornell Research Foundation, Inc. |
Method of treating cancer
|
US20040121946A9
(en)
|
2000-12-11 |
2004-06-24 |
John Fikes |
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
|
US6632459B2
(en)
|
2000-12-11 |
2003-10-14 |
Nutricia N.V. |
Chlorogenic acid and an analog thereof for immune system stimulation
|
HUP0402656A3
(en)
|
2001-02-20 |
2012-03-28 |
Ortho Mcneil Pharm Inc |
A cell therapy method for the treatment of tumors
|
ES2394293T3
(es)
|
2001-02-28 |
2013-01-30 |
Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. |
Vacuna contra cánceres que están asociados con el oncogén HER-2/neu
|
CN1168740C
(zh)
|
2001-04-04 |
2004-09-29 |
上海美恩生物技术有限公司 |
细胞因子基因修饰的抗原提呈细胞/肿瘤细胞偶联物、其制法和用途
|
DE10132502A1
(de)
|
2001-07-05 |
2003-01-23 |
Gsf Forschungszentrum Umwelt |
Angriff auf Tumorzellen mit fehlender, niedriger oder anormaler MHC-Expression durch kombinieren von nicht MHC-Restringierten T-Zellen/NK-Zellen und MHC-Restringierten Zellen
|
US20040241147A1
(en)
|
2001-07-25 |
2004-12-02 |
Alessandra Nardin |
New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
|
GB0119346D0
(en)
|
2001-08-08 |
2001-10-03 |
Bioclones Proprietary Ltd |
Process for the maturation of dendritic cells
|
CA2457143A1
(en)
|
2001-08-17 |
2003-02-27 |
Roger Williams Hospital |
In situ immunization
|
WO2003022215A2
(en)
|
2001-09-06 |
2003-03-20 |
Northwest Biotherapeutics, Inc. |
Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
|
US20040072246A1
(en)
|
2001-09-11 |
2004-04-15 |
Roland Martin |
System and method for identifying t cell and other epitopes and the like
|
EP1810691A3
(en)
|
2001-10-26 |
2008-03-26 |
IRX Therapeutics, Inc. |
Immunotherapy for reversing immune suppression
|
AU2003206865B2
(en)
|
2002-02-08 |
2007-10-04 |
D. Collen Research Foundation Vzw |
A novel target to inhibit angiogenesis
|
CA2480008C
(en)
|
2002-03-22 |
2015-10-06 |
The Penn State Research Foundation |
Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
|
US7413869B2
(en)
|
2002-04-05 |
2008-08-19 |
Dendreon Corporation |
Method for determining potency of antigenic presenting cell based vaccines
|
US7204982B2
(en)
|
2002-07-02 |
2007-04-17 |
The Regents Of The University Of California |
Compositions and methods for treatment and detection of multiple cancers
|
US20090110702A1
(en)
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
US20040057935A1
(en)
|
2002-09-20 |
2004-03-25 |
Cedars-Sinai Medical Center |
Intratumoral delivery of dendritic cells
|
US20040197903A1
(en)
|
2003-01-31 |
2004-10-07 |
Northwest Biotherapeutics, Inc. |
Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15
|
AU2004214896A1
(en)
|
2003-02-27 |
2004-09-10 |
Northwest Biotherapeutics, Inc. |
Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
|
JP2007507543A
(ja)
|
2003-10-06 |
2007-03-29 |
セダーズ−シナイ メディカル センター |
樹状細胞治療によって誘導されるt細胞アネルギーを予防するためのcox−2インヒビターの使用
|
WO2005043155A1
(en)
|
2003-10-21 |
2005-05-12 |
Cedars-Sinai Medical Center |
System and method for the treatment of cancer, including cancers of the central nervous system
|
WO2005079581A1
(en)
|
2004-01-20 |
2005-09-01 |
Cedars-Sinai Medical Center |
Intratumoral delivery of dendritic cells
|
WO2006034334A2
(en)
|
2004-09-21 |
2006-03-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
|
WO2006099448A2
(en)
|
2005-03-14 |
2006-09-21 |
University Of Iowa Research Foundation |
Accelerated cd8+ t-cell memory after dendritic cell vaccination
|
US7842466B1
(en)
|
2005-09-16 |
2010-11-30 |
Celera Corporation |
Colon disease targets and uses thereof
|
US20100040637A1
(en)
|
2005-11-23 |
2010-02-18 |
Karen Van Orden |
Methods and Composition for Treating Diseases Targeting Prominin-1 (CD133)
|
US20080107668A1
(en)
|
2006-08-30 |
2008-05-08 |
Immunotope, Inc. |
Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
WO2008039874A2
(en)
|
2006-09-26 |
2008-04-03 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
WO2008039969A2
(en)
|
2006-09-28 |
2008-04-03 |
Cedars-Sinai Medical Center |
Cancer vaccines and vaccination methods
|
ITMI20062100A1
(it)
|
2006-10-31 |
2008-05-01 |
Fondazione I R C C S Istituto Neurologico |
Metodo per la stimolazi0ne di cellule dendritiche e prodotto cellulare cosi'ottenuto per la immunoterapia autologa di tumori solidi umani
|
CA2668223A1
(en)
|
2006-10-31 |
2008-05-08 |
National Stem Cell Holding Inc. |
Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
US8168586B1
(en)
|
2007-11-21 |
2012-05-01 |
Celera Corporation |
Cancer targets and uses thereof
|
PL2328923T3
(pl)
|
2008-09-02 |
2016-06-30 |
Cedars Sinai Medical Center |
Epitopy CD133
|
PL2427485T3
(pl)
|
2009-05-07 |
2017-10-31 |
Immunocellular Therapeutics Ltd |
Epitopy CD133
|
WO2012027379A2
(en)
|
2010-08-24 |
2012-03-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
EP3305798A1
(en)
|
2010-12-09 |
2018-04-11 |
The Trustees of The University of Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
US9187534B2
(en)
|
2011-03-11 |
2015-11-17 |
Universite De Geneve |
Multi-epitopic vaccine
|
US20140234350A1
(en)
|
2013-02-14 |
2014-08-21 |
Cedars-Sinai Medical Center |
Ovarian cancer vaccines and vaccination methods
|
CA2898474A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd. |
Cancer vaccines and vaccination methods
|